Reilly, Janiczek, McDevitt, Henrich & Cholden’s Pharmaceutical practice brings its long history of experience in acting as both regional and national counsel in other mass tort litigation to the pharmaceutical industry’s high profile matters, including most recently the metoclopramide litigation. The Reilly, Janiczek, McDevitt, Henrich & Cholden attorneys combine their extensive experience in a variety of products liability cases with their continued pursuit of identifying new legal and medical theories to defend against claims of manufacturing or design defects, and claims involving strict liability, breach of warranty, and failure to warn in the pharmaceutical industry.
Our clients include domestic and international manufacturers as well as insurance companies representing such companies. Our firm has extensive relationships with lawyers in other states, and often coordinates and oversees the work of multiple law firms in the mass tort litigation which has assisted our firm in establishing early credibility for our clients in a variety of cases. Our firm has concentrated its practice on products liability defense since the firm opened, and in turn, the firm has an experienced group of trial lawyers who are extremely familiar with the medical and legal issues of this rapidly changing litigation landscape. Our clients appreciate our trial experience, relationships with plaintiff and co-defendant’s counsel as well as the Court in addition to our proven results at trial.